
Ubigene gene knockout cell lines mediated by optimized CRISPR-Cas9 technology provide reliable in vitro models for investigating gene function, signaling pathways, disease mechanisms, and therapeutic targets.
ZNF607 (zinc finger protein 607) encodes a predicted DNA-binding transcription factor with RNA polymerase II-specific and cis-regulatory region sequence-specific DNA-binding activity. The protein is predicted to participate in regulation of transcription by RNA polymerase II and is also predicted to be associated with the mitochondrial inner membrane and nucleus. Its specific molecular functions remain incompletely characterized.
Human normal colonic epithelial cells are represented by NCM460, a cell line derived from normal colonic mucosa rather than a malignant tumor. The cells are classified as human intestinal epithelial cells and are commonly used as a non-tumorigenic intestinal epithelial model.
Before delivery, each clone is authenticated by STR, tested for sterility and mycoplasma, and genotype‑verified by two‑round PCR‑sequencing. Comprehensive QC data accompany every shipment to support reproducible research.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.

Targeted knockout region: EExon 3
Reference Transcript: NM_001375895
Frameshift Mutation Strategy
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use





Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours.
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?